Overview

Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab

Status:
Terminated

Trial end date:
2015-03-01

Target enrollment:

Participant gender:

Summary

To determine if patients treated early after diagnosis of wet age-related macular degeneration can return/maintain to their baseline pre-disease BCVA.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Kang Zhang, MD, PhD
University of California, San Diego

Collaborator:

Genentech, Inc.

Treatments:

Ranibizumab